La Roquette

La Roquette is a leading global provider of raw materials, specializing in the production of starch and starch derivatives, as well as polyols. The company serves a diverse range of industrial sectors, with a strong emphasis on the pharmaceutical industry, where it supplies pyrogen-free raw materials and cationic starches. La Roquette's manufacturing facilities across Europe, America, and Asia utilize renewable raw materials such as maize, wheat, potatoes, and peas, ensuring a clear and secure supply chain for its partners and customers. The company is committed to high performance standards and employs established methods to guarantee the consistency and reliability of its ingredients. With over 700 products in global demand, La Roquette's dedication to quality and innovation is reflected in its robust research, sourcing, production, and delivery systems.

Edouard Nuttin

CEO

10 past transactions

Pharma Solutions at IFF

Acquisition in 2024
Pharma Solutions is a one-of-a-kind portfolio with critical expertise that helps customers solve problems and deliver on the promise of a better life.

DAIZ

Series C in 2023
DAIZ Inc., founded in 2015 and based in Kumamoto, Japan, specializes in the production and supply of plant-based meat products, notably under the brand name 'Miracle Meat.' Utilizing a proprietary process known as the 'Ochiai Germination Method,' the company transforms germinated soybeans into functional food substances that serve as healthy, plant-based alternatives to traditional meat. In addition to its production activities, DAIZ is involved in research and development focused on raw materials and drug discovery derived from germinated soybeans, further emphasizing its commitment to innovation in the plant-based food sector.

Rival Foods

Series A in 2022
Rival Foods specializes in food production and manufacturing and offers plant-based culinary whole-cuts. The company brings culinary plant-based alternatives to traditional protein sources such as meat and fish not compromising on taste and experience.

Magellan Life Sciences

Seed Round in 2021
Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, specializing in the development of plant-based proteins for the food and beverage industries. Established in 2018, the company focuses on creating innovative protein sweeteners, including brazzein, utilizing its proprietary protein engineering and expression platforms. These novel protein-based molecules are designed to offer non-calorific alternatives that address sugar content and associated health concerns. By providing advanced solutions for the food, health, and nutrition sectors, Magellan Life Sciences aims to meet the growing demand for healthier ingredients in consumer products.

Nxtfood

Venture Round in 2021
Nxtfood offers a range of food products, including vegetarian irish pie, vegetarian shepherd's pie with sweet potato, vegetarian meatballs, vegetarian mushroom pie, vegetarian pithiviers, welsh vegetarian, vegetarian stuffed cabbage, vegetarian stuffed butternut, and more.

The Protein Brewery

Series A in 2020
The Protein Brewery B.V., founded in 2019 and based in Breda, the Netherlands, specializes in the development, manufacture, and commercialization of sustainable animal-free proteins. The company focuses on producing Fermotein, a fungi-based protein created through advanced fermentation technologies. This innovative approach enables the company to utilize significantly less land and water compared to traditional animal protein production methods, while still delivering high yields and maintaining taste and nutritional quality. The Protein Brewery aims to provide consumers with protein-integrated foods that contain essential amino acids, vitamins, and minerals necessary for a healthy and balanced diet.

Equinom

Series B in 2020
Equinom is a food-tech company focused on developing sustainable, non-GMO plant-based ingredients through innovative agricultural practices and advanced technology. It addresses the challenge of inadequate crop production for human consumption, as many crops are traditionally grown for animal feed, requiring costly processing to make them suitable for food. By leveraging its proprietary Manna™ technology platform, Equinom employs artificial intelligence to accelerate the development of high-yield, naturally bred crops that enhance the taste, nutrition, and affordability of meat and dairy alternatives. This approach not only ensures quality and consumer satisfaction but also promotes biodiversity and climate resilience, critical for future food security in the face of climate change. Collaborating with various partners, Equinom has gained recognition as a reliable supplier of premium ingredients, supported by notable investors that bolster its position in the rapidly growing plant-based food market.

Reverdia

Acquisition in 2019
Reverdia manufactures and markets bio-based succinic acid and derivatives on applications which includes butanediol, polyurethane resins, and biopolymers. It was founded in 2010 and is based in the Netherlands.

Equinom

Venture Round in 2017
Equinom is a food-tech company focused on developing sustainable, non-GMO plant-based ingredients through innovative agricultural practices and advanced technology. It addresses the challenge of inadequate crop production for human consumption, as many crops are traditionally grown for animal feed, requiring costly processing to make them suitable for food. By leveraging its proprietary Manna™ technology platform, Equinom employs artificial intelligence to accelerate the development of high-yield, naturally bred crops that enhance the taste, nutrition, and affordability of meat and dairy alternatives. This approach not only ensures quality and consumer satisfaction but also promotes biodiversity and climate resilience, critical for future food security in the face of climate change. Collaborating with various partners, Equinom has gained recognition as a reliable supplier of premium ingredients, supported by notable investors that bolster its position in the rapidly growing plant-based food market.

Itacel

Acquisition in 2017
Itacel operates as a player in the pharmaceutical excipients market in Brazil and Latin America. Itacel offers a large range of products to an attractive client base that includes major pharmaceutical and food companies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.